SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shivalik Rasayan gains on inking marketing agreement with China Chinopharma

03 Aug 2022 Evaluate

Shivalik Rasayan is currently trading at Rs. 853.00, up by 3.00 points or 0.35% from its previous closing of Rs. 850.00 on the BSE.

The scrip opened at Rs. 838.95 and has touched a high and low of Rs. 874.00 and Rs. 837.60 respectively. So far 214 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 1196.80 on 06-Jan-2022 and a 52 week low of Rs. 661.05 on 20-Jun-2022.

Last one week high and low of the scrip stood at Rs. 874.00 and Rs. 733.20 respectively. The current market cap of the company is Rs. 1235.93 crore.

The promoters holding in the company stood at 50.32%, while Institutions and Non-Institutions held 0.04% and 49.64% respectively.

Shivalik Rasayan (SRL) has entered into a long term marketing Agreement with China Chinopharma (CSC) to supply DMF grade Busalfan, API. The CSC shall hold Market Authorisation (MA) to sell SRL's Busalfan, API exclusively in China territory.

The CSC is a leader and pioneer who specialises in dealing with Pharmaceutical products having more than 20 years of experience.

Shivalik Rasayan is a manufacturer of organophosphorous based insecticides and chemicals.

Shivalik Rasayan Share Price

273.20 -5.55 (-1.99%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 656.15
PI Industries 3036.95
Bayer CropScience 4852.90
Sharda Cropchem 1101.50
Sumitomo Chemical 446.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×